Protagenic Therapeutics, Inc. announced that at the Annual Meeting of Stockholders held on November 23, 2022 approved the election of Timothy R. Wright as a Class I director to serve their terms until the Company's 2025 Annual Meeting of Stockholders, and until their respective successors are duly elected and qualified.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.41 USD | +1.81% | +12.80% | +42.42% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+42.42% | 6.25M | |
+1.77% | 42.86B | |
+47.70% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- PTIX Stock
- News Protagenic Therapeutics, Inc.
- Protagenic Therapeutics, Inc. Appoints Timothy R. Wright as a Class I Director